Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia

Transplantation

Volumn 73, Issue 1, 2002, Pages 104-111

  Wickenhauser, Claudia ^a   Thiele, Juergen ^a   Pérez, Fernando ^a   Varus, Eva ^a   Stoffel, Marc Sebastian ^a   Kvasnicka, Hans Michael ^a   Beelen, Dietrich Wilhelm ^b   Schaefer, Ullrich Wilhelm ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CANCER RECURRENCE; CELL CLONE; CELL LINEAGE; CELL POPULATION; CELL TYPE; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA CELL; MACROPHAGE; MALE; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME;

EID: 0037080948     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200201150-00020     Document Type: Article

References (47)

1. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages
2. The Philadelphia chromosome in human macrophages
3. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy: A fluorescence in situ hybridization study on trephine biopsies
4. Acquired lipidosis of marrow macrophages: Birefringent blue crystals and Gaucher-like cells, sea-blue histiocytes, and grey-green crystals
5. Gaucher cells in chronic myelocytic leukemia: An acquired abnormality
6. Sea-blue histiocytes and Gaucher cells in bone marrow of patients with chronic myeloid leukaemia
7. Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia
8. Bone marrow histopathology in chronic myelogenous leukemia (CML)-evaluation of distinctive features with clinical impact
9. Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive
10. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay
11. Chimerism studies using in situ hybridization for the Y chromosome after T-cell-depleted bone marrow
12. Incidence of mixed chimerism using busulfan/cyclophosphamide containing regimens in allogeneic bone marrow transplantation
13. Detection of residual host cells after bone marrow transplantation using nonisotopic in situ hybridization and karyotype analysis
14. Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization
15. Application of Interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation
16. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation
17. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells
18. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia
19. Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy
20. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
21. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: Increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse
22. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: A review of recent results
23. Expression of BCR-ABL fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia
24. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction
25. Clinical significance of BCR-ABL gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia
26. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia
27. Long persistent BCR-ABL positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients
28. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Correlations with acute graft-versus-host disease and relapse
29. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients
30. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation
31. Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages: Immunohistochemical and morphometric study including reactive (inflammatory) myelitis, secondary aplastic anemia, AIDS, myelodysplastic syndromes and primary (idiopathic) osteomyelofibrosis
32. Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosomepositive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome
33. Bone marrow transplantation for chronic myelogenous leukemia
34. Allografting for chronic myeloid leukaemia
35. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
36. Bone marrow features and clinical findings in chronic myeloid leukemia: A comparative, multicenter, immunohistological and morphometric study on 614 patients
37. Efficient nuclear FISH on paraffin-embedded tissue sections using microwave pretreatment
38. A role for the macrophage in normal hemopoiesis. II. Effect of varying physiological oxygen tensions on the release of hemopoietic growth factors from bone-marrow-derived macrophages in vitro
39. The role of macrophages in the regulation of erythroid colony growth in vitro
40. Microenvironmental factors involved in the establishment of erythropoiesis in bone marrow
41. Importance of cell-cell interactions in regulation of erythropoiesis
42. Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells
43. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation
44. Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease
45. Natural history of mixed chimerism after bone marrow transplantation with CD6 depleted allogeneic marrow: A stable equilibrium
46. Partial chimerism after T-cell depleted, allogeneic bone marrow transplantation in leukemic HLA-matched patients: A cytogenetic documentation
47. Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction